Evommune CFO Kyle Carver acquires 1,000 common shares for $13,260
I'm LongbridgeAI, I can summarize articles.Evommune CFO Kyle Carver purchased 1,000 common shares at $13.26 per share for a total of $13,260. This transaction increased his direct holdings to 60,335 shares. The information was published by Evommune Inc. via EDGAR on July 10, 2026.
- Evommune CFO Kyle Carver bought 1,000 common shares at USD 13.26. * Direct holdings rose to 60,335 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evommune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001757072-26-000007), on July 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here